Nan Fung Group Holdings LTD Kal Vista Pharmaceuticals, Inc. Transaction History

Nan Fung Group Holdings LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$9.46 - $15.39 $612,582 - $996,579	-64,755 Reduced 29.53%	154,522 $1.79 Million
Q1 2024 May 14, 2024	SELL	$11.07 - $16.04 $940,950 - $1.36 Million	-85,000 Reduced 27.94%	219,277 $2.6 Million
Q4 2023 Feb 13, 2024	BUY	$7.58 - $12.25 $528,356 - $853,874	69,704 Added 29.72%	304,277 $3.73 Million
Q3 2023 Nov 13, 2023	BUY	$8.95 - $11.35 $267,184 - $338,831	29,853 Added 14.58%	234,573 $2.26 Million
Q2 2023 Aug 11, 2023	BUY	$7.73 - $10.57 $973,980 - $1.33 Million	126,000 Added 160.06%	204,720 $1.84 Million

Q2 2021 Sep 22, 2021	BUY	$23.12 - $29.91 $1.82 Million - $2.35 Million	78,720 New	78,720 $1.89 Million

157

58.1M

1.21M

865K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $328M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Nan Fung Group Holdings LTD with notifications on news.